Unique ID issued by UMIN | UMIN000021866 |
---|---|
Receipt number | R000025211 |
Scientific Title | The Retrospective Study of MUC1-targeted Dendritic Cell-based Vaccine in Patients with Refractory Non-small Cell Lung Cancer |
Date of disclosure of the study information | 2016/04/12 |
Last modified on | 2016/04/11 16:02:47 |
The Retrospective Study of MUC1-targeted Dendritic Cell-based Vaccine in Patients with Refractory Non-small Cell Lung Cancer
MUC1-targeted Dendritic Cell-based Vaccine in Patients with Refractory Non-small Cell Lung Cancer
The Retrospective Study of MUC1-targeted Dendritic Cell-based Vaccine in Patients with Refractory Non-small Cell Lung Cancer
MUC1-targeted Dendritic Cell-based Vaccine in Patients with Refractory Non-small Cell Lung Cancer
Japan |
Non-small cell lung cancer
Pneumology | Chest surgery |
Malignancy
NO
To evaluate safety and efficacy of MUC1-targeted dendritic cell-based vaccine in patients with refractory non-small cell lung cancer, retrospectively.
Safety,Efficacy
Efficacy (Overall survival from the initial vaccination)
Safety(Incidence and grade of adverse events)
Anti-tumor effect after the six vaccinations
Immunological responses after the six vaccinations (MUC1-specific cytotoxicity and frequency of regulatory T cells in peripheral blood)
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Between August 2005 and May 2015, NSCLC patients who were treated with MUC1-targeted dendritic cell-based vaccines as an advanced medical treatment approved by the Ministry of Health, Labor and Welfare, Japan, in Shiga University of Medical Science Hospital.
Patients with NSCLC that was not refractory for some standard cancer treatments.
40
1st name | |
Middle name | |
Last name | Koji Teramoto |
Shiga University of Medical Science
Department of Medical Oncology
Seta-Tsukinowa, Otsu, Shiga
077-548-3590
teramoto@belle.shiga-med.ac.jp
1st name | |
Middle name | |
Last name | Koji Teramoto |
Shiga University of Medical Science
Department of Medical Oncology
Seta-Tsukinowa, Otsu, Shiga
077-548-3590
teramoto@belle.shiga-med.ac.jp
Shiga University of Medical Science
Shiga University of Medical Science
Other
NO
2016 | Year | 04 | Month | 12 | Day |
Unpublished
Completed
2015 | Year | 04 | Month | 01 | Day |
2015 | Year | 04 | Month | 01 | Day |
To Evaluate an association between overall survival time form the initial vaccination and immune-related adverse events or frequency of peripheral lymphocytes.
2016 | Year | 04 | Month | 11 | Day |
2016 | Year | 04 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025211
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |